Skip to content

A retrospective cross-sectional study exploring serum magnesium and diabetic retinopathy in patients with type 2 diabetes mellitus

A retrospective cross-sectional study exploring serum magnesium and diabetic retinopathy in patients with type 2 diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041066
Enrollment
Unknown
Registered
2020-12-17
Start date
2020-12-15
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus, diabetic retinopathy

Interventions

Diabetic retinopathy group:Nil
non-diabetic retinopathy group:Nil

Sponsors

Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-80 years; (2) Patients with type 2 diabetes.

Exclusion criteria

Exclusion criteria: (1) Diabetic acute complications; (2) severe hepatic insufficiency or heart failure; (3) severe renal failure or combined with other kidney disease (such as glomerulonephritis, nephrotic syndrome and interstitial nephritis); (4) history of malignancy, hematologic disease, autoimmune disease or other endocrine disease (such as hyperthyroidism, hypothyroidism or hyperparathyroidism); (5) pregnancy; (6) acute infection; (7) taking some drugs that may influence serum Mg2+ excretion, like diuretics, aminoglycoside antibiotics and amphotericin B.

Design outcomes

Primary

MeasureTime frame
serum magnesium;

Secondary

MeasureTime frame
glycosylated hemoglobin;fasting plasma glucose;c peptide;Total cholesterol;triglycerides;free fatty acid;Low density lipoprotein cholesterol;

Countries

China

Contacts

Public ContactZhao Wenjuan

Affiliated Hospital of Qingdao University

18661807103@163.com+86 18661807103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026